StockData
Adicet Bio, Inc. logo

Adicet Bio, Inc. (ACET) stock

ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$2.78+0.03 (+1.09%)

Close on Nov 17, 2026Market cap $26.02MP/E –Yield –

Adicet Bio revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Adicet Bio

Adicet Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Adicet Bio figures

See a number that looks wrong?